Company

Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals developed biopharmaceutical treatments for metabolic diseases.

About

Omthera Pharmaceuticals developed biopharmaceutical treatments for metabolic diseases and cardiovascular conditions. Founded in 2008, it was based in Bedminster, US. AstraZeneca acquired the company in 2013 for USD 323 million, with up to USD 120 million additional payments based on drug performance.

4Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in